https://www.pharmaradar360.com/article/db856c0240490cc2PharmaRadar360en2026-04-07T11:32:38.000ZNatac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeholder Forum 202607/04/2026Industrial biotechnologyAntonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based…Partners - Natac Grouphttps://www.pharmaradar360.com/article/06a1c299ee5a17a2PharmaRadar360en2026-04-07T07:00:00.000ZSkye Bioscience Presenting at GLP-1-Based Therapeutics Summithttps://www.pharmaradar360.com/article/eaa9007bf360d765PharmaRadar360en2026-04-07T00:00:00.000ZPharming Group to participate in April investor conferencesConference attendanceApril 7 2026Pharming Group N.V. today announced that its management will participate in the following investor conferences in the month of April:Read morehttps://www.pharmaradar360.com/article/11c35d24d5834c31PharmaRadar360en2026-04-07T00:00:00.000ZPharmacists at Orion – The many paths a pharmacy degree can open up in the pharmaceutical industry4/7/2026 We are Orion Pharmahttps://www.pharmaradar360.com/article/017bd5fd197d16e3PharmaRadar360en2026-04-07T00:00:00.000ZISPOR Publishes Recommendations on Valuing Child and Adolescent Health for Economic Evaluationshttps://www.pharmaradar360.com/article/5699bcb7e99adc87PharmaRadar360en2026-04-07T00:00:00.000ZNuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLChttps://www.pharmaradar360.com/article/66a6c858155ca3f1PharmaRadar360en2026-04-06T16:00:00.000ZSector tariff now more than a threat – for some Rx companieshttps://www.pharmaradar360.com/article/42c4b81b3da7cfc4PharmaRadar360en2026-04-06T12:30:00.000ZAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)https://www.pharmaradar360.com/article/e484886095722acfPharmaRadar360en2026-04-06T11:22:39.000ZCRC Confessionals: The Support I Never Dreamed I Could Havehttps://www.pharmaradar360.com/article/30fed1b03cacf439PharmaRadar360en2026-04-06T06:30:00.000Z大阪大学免疫学フロンティア研究センターとの共同研究による免疫性血小板減少症に関する研究成果がBlood誌に掲載https://www.pharmaradar360.com/article/30de1058add9bb79PharmaRadar360en2026-04-06T06:30:00.000ZResearch Results on Immune Thrombocytopenia from a Joint Study with Osaka University’s IFReC Published in Bloodhttps://www.pharmaradar360.com/article/4bdde72027b7c6d4PharmaRadar360en2026-04-06T03:00:00.000Z[SHINSA]List of Approved Drugs: April 2004 to September 2025https://www.pharmaradar360.com/article/d751e33aa5c6e59dPharmaRadar360en2026-04-06T03:00:00.000Z[SHINSA]Software as a Medical Device (SaMD) page updatedhttps://www.pharmaradar360.com/article/3f4eae7978d5bfb6PharmaRadar360en2026-04-06T02:45:00.000ZRelics of an ancient sandstorm on Mars point to Earth-like winds